Dag Nyholm

Comparative outcomes and healthcare costs of three device-aided pharmacotherapies for patients with advanced Parkinson's disease in Sweden: A nationwide registry-based cohort study

Nyholm, Dag; Paonessa, Davide; Bergquist, Filip; Timmermann, Jan Erik et al.

Ingår i Parkinsonism & Related Disorders, 2026

• DOI för Comparative outcomes and healthcare costs of three device-aided pharmacotherapies for patients with advanced Parkinson's disease in Sweden: A nationwide registry-based cohort study
• Ladda ner fulltext (pdf) av Comparative outcomes and healthcare costs of three device-aided pharmacotherapies for patients with advanced Parkinson's disease in Sweden: A nationwide registry-based cohort study

Inflammatory protein profiles and shunt response in iNPH

Braun, Madelen; Ekblom, Maria; Freyhult, Eva; Åberg, Mikael et al.

Ingår i Fluids and Barriers of the CNS, 2026

• DOI för Inflammatory protein profiles and shunt response in iNPH
• Ladda ner fulltext (pdf) av Inflammatory protein profiles and shunt response in iNPH

Characterization of a distinct form of vimentin in the neurodegenerative brain

Dakhel, Abdulkhalek; Vestin, Johanna; Giedraitis, Vilmantas; Nyholm, Dag et al.

Ingår i Acta neuropathologica communications, 2026

• DOI för Characterization of a distinct form of vimentin in the neurodegenerative brain
• Ladda ner fulltext (pdf) av Characterization of a distinct form of vimentin in the neurodegenerative brain

Safety, tolerability, and efficacy of acetazolamide in idiopathic normal pressure hydrocephalus (DRAIN) in Sweden: a randomised, double-blind, placebo-controlled phase 2 trial

Virhammar, Johan; Fasth, Oskar; Ekblom, Maria; Ekman, Oskar et al.

Ingår i Lancet Neurology, s. 550-559, 2026

• DOI för Safety, tolerability, and efficacy of acetazolamide in idiopathic normal pressure hydrocephalus (DRAIN) in Sweden: a randomised, double-blind, placebo-controlled phase 2 trial

COMT inhibition with entacapone for patients with Parkinson’s disease and motor complications: the novelty of continuous infusion

Jenner, Peter; Nyholm, Dag

Ingår i Journal of neural transmission, s. 361-375, 2026

• DOI för COMT inhibition with entacapone for patients with Parkinson’s disease and motor complications: the novelty of continuous infusion
• Ladda ner fulltext (pdf) av COMT inhibition with entacapone for patients with Parkinson’s disease and motor complications: the novelty of continuous infusion

Comparative outcomes and healthcare costs of three device-aided pharmacotherapies for patients with advanced Parkinson's disease in Sweden: A nationwide registry-based cohort study

Nyholm, Dag; Paonessa, Davide; Bergquist, Filip; Timmermann, Jan Erik et al.

Ingår i Parkinsonism & Related Disorders, 2026

• DOI för Comparative outcomes and healthcare costs of three device-aided pharmacotherapies for patients with advanced Parkinson's disease in Sweden: A nationwide registry-based cohort study
• Ladda ner fulltext (pdf) av Comparative outcomes and healthcare costs of three device-aided pharmacotherapies for patients with advanced Parkinson's disease in Sweden: A nationwide registry-based cohort study

Inflammatory protein profiles and shunt response in iNPH

Braun, Madelen; Ekblom, Maria; Freyhult, Eva; Åberg, Mikael et al.

Ingår i Fluids and Barriers of the CNS, 2026

• DOI för Inflammatory protein profiles and shunt response in iNPH
• Ladda ner fulltext (pdf) av Inflammatory protein profiles and shunt response in iNPH

Characterization of a distinct form of vimentin in the neurodegenerative brain

Dakhel, Abdulkhalek; Vestin, Johanna; Giedraitis, Vilmantas; Nyholm, Dag et al.

Ingår i Acta neuropathologica communications, 2026

• DOI för Characterization of a distinct form of vimentin in the neurodegenerative brain
• Ladda ner fulltext (pdf) av Characterization of a distinct form of vimentin in the neurodegenerative brain

Safety, tolerability, and efficacy of acetazolamide in idiopathic normal pressure hydrocephalus (DRAIN) in Sweden: a randomised, double-blind, placebo-controlled phase 2 trial

Virhammar, Johan; Fasth, Oskar; Ekblom, Maria; Ekman, Oskar et al.

Ingår i Lancet Neurology, s. 550-559, 2026

• DOI för Safety, tolerability, and efficacy of acetazolamide in idiopathic normal pressure hydrocephalus (DRAIN) in Sweden: a randomised, double-blind, placebo-controlled phase 2 trial

COMT inhibition with entacapone for patients with Parkinson’s disease and motor complications: the novelty of continuous infusion

Jenner, Peter; Nyholm, Dag

Ingår i Journal of neural transmission, s. 361-375, 2026

• DOI för COMT inhibition with entacapone for patients with Parkinson’s disease and motor complications: the novelty of continuous infusion
• Ladda ner fulltext (pdf) av COMT inhibition with entacapone for patients with Parkinson’s disease and motor complications: the novelty of continuous infusion

A data-driven SSM/PCA analysis approach for differential diagnosis of parkinsonism using ¹¹C-PE2I PET

Falk, Linus; Brunius, Carl; Bojkovic, Tea Crnic; Appel, Lieuwe et al.

Ingår i NeuroImage, 2026

• DOI för A data-driven SSM/PCA analysis approach for differential diagnosis of parkinsonism using ¹¹C-PE2I PET
• Ladda ner fulltext (pdf) av A data-driven SSM/PCA analysis approach for differential diagnosis of parkinsonism using ¹¹C-PE2I PET

Therapies for Advanced Parkinson's Disease in Sweden: A Cost-Effectiveness Analysis Using Real-World Data

Nyholm, Dag; Eggington, Simon; Holm, Astrid

Ingår i Neurology and Therapy, s. 801-812, 2025

• DOI för Therapies for Advanced Parkinson's Disease in Sweden: A Cost-Effectiveness Analysis Using Real-World Data
• Ladda ner fulltext (pdf) av Therapies for Advanced Parkinson's Disease in Sweden: A Cost-Effectiveness Analysis Using Real-World Data

Fiber Activation in Bipolar Deep Brain Stimulation: A Patient Case Study

Frigge, Anna F.; Jiltsova, Elena; Olsson, Fredrik; Nyholm, Dag et al.

Ingår i IFAC-PapersOnLine, s. 361-366, 2025

• DOI för Fiber Activation in Bipolar Deep Brain Stimulation: A Patient Case Study
• Ladda ner fulltext (pdf) av Fiber Activation in Bipolar Deep Brain Stimulation: A Patient Case Study

NLX-112 Randomized Phase 2A Trial: Safety, Tolerability, Anti-Dyskinetic, and Anti-Parkinsonian Efficacy

Svenningsson, Per; Odin, Per; Bergquist, Filip; Wirdefeldt, Karin et al.

Ingår i Movement Disorders, s. 1134-1142, 2025

• DOI för NLX-112 Randomized Phase 2A Trial: Safety, Tolerability, Anti-Dyskinetic, and Anti-Parkinsonian Efficacy
• Ladda ner fulltext (pdf) av NLX-112 Randomized Phase 2A Trial: Safety, Tolerability, Anti-Dyskinetic, and Anti-Parkinsonian Efficacy

Blinded gait assessment in idiopathic normal pressure hydrocephalus: reliability and correlation with clinical and patient-reported outcomes

Ekblom, Maria; Nyholm, Dag; Zetterberg, Lena; Laurell, Katarina et al.

Ingår i Fluids and Barriers of the CNS, 2025

• DOI för Blinded gait assessment in idiopathic normal pressure hydrocephalus: reliability and correlation with clinical and patient-reported outcomes
• Ladda ner fulltext (pdf) av Blinded gait assessment in idiopathic normal pressure hydrocephalus: reliability and correlation with clinical and patient-reported outcomes

“I’m still the person I am. Not the body it has become.”: An active but challenging life with cervical dystonia

Zetterberg, Lena; Niemi Andersson, Ewa; Åsenlöf, Pernilla; Nyholm, Dag et al.

Ingår i Physiotherapy Theory and Practice, s. 763-771, 2025

• DOI för “I’m still the person I am. Not the body it has become.”: An active but challenging life with cervical dystonia
• Ladda ner fulltext (pdf) av “I’m still the person I am. Not the body it has become.”: An active but challenging life with cervical dystonia

Levodopa-entacapone-carbidopa intestinal gel: Data from the Swedish national registry for Parkinson's disease

Öthman, Mezin; Bergquist, Filip; Odin, Per; Scharfenort, Monica et al.

Ingår i European Journal of Neurology, 2025

• DOI för Levodopa-entacapone-carbidopa intestinal gel: Data from the Swedish national registry for Parkinson's disease
• Ladda ner fulltext (pdf) av Levodopa-entacapone-carbidopa intestinal gel: Data from the Swedish national registry for Parkinson's disease

Quantitative brain stem assessment in discriminating neurodegenerative disorders from normal pressure hydrocephalus

Georgiopoulos, Charalampos; Papadimitriou, Stergios; Nyholm, Dag; Kilander, Lena et al.

Ingår i Journal of Neuroimaging, s. 612-618, 2024

• DOI för Quantitative brain stem assessment in discriminating neurodegenerative disorders from normal pressure hydrocephalus
• Ladda ner fulltext (pdf) av Quantitative brain stem assessment in discriminating neurodegenerative disorders from normal pressure hydrocephalus

Pain in patients with motor neuron disease: Variation of pain and association with disease severity, health-related quality of life and depression – A longitudinal study

Spörndly-Nees, Sören; Jakobsson Larsson, Birgitta; Zetterberg, Lena; Åkerblom, Ylva et al.

Ingår i Palliative & Supportive Care, s. 1150-1157, 2024

• DOI för Pain in patients with motor neuron disease: Variation of pain and association with disease severity, health-related quality of life and depression – A longitudinal study
• Ladda ner fulltext (pdf) av Pain in patients with motor neuron disease: Variation of pain and association with disease severity, health-related quality of life and depression – A longitudinal study

A 4‐Year Follow‐Up of Levodopa‐Entacapone‐Carbidopa Intestinal Gel Treatment in Parkinson's Disease

Öthman, Mezin; Nyholm, Dag

Ingår i Movement Disorders Clinical Practice, s. 1609-1612, 2024

• DOI för A 4‐Year Follow‐Up of Levodopa‐Entacapone‐Carbidopa Intestinal Gel Treatment in Parkinson's Disease
• Ladda ner fulltext (pdf) av A 4‐Year Follow‐Up of Levodopa‐Entacapone‐Carbidopa Intestinal Gel Treatment in Parkinson's Disease

Motor Efficacy of Subcutaneous DIZ102, Intravenous DIZ101 or Intestinal Levodopa/Carbidopa Infusion

Bergquist, Filip; Ehrnebo, Mats; Nyholm, Dag; Johansson, Anders et al.

Ingår i Movement Disorders Clinical Practice, s. 1095-1102, 2024

• DOI för Motor Efficacy of Subcutaneous DIZ102, Intravenous DIZ101 or Intestinal Levodopa/Carbidopa Infusion
• Ladda ner fulltext (pdf) av Motor Efficacy of Subcutaneous DIZ102, Intravenous DIZ101 or Intestinal Levodopa/Carbidopa Infusion

Comparison of quantitative [11C]PE2I brain PET studies between an integrated PET/MR and a stand-alone PET system

Sousa, Joao M.; Appel, Lieuwe; Engstrom, Mathias; Nyholm, Dag et al.

Ingår i Physica medica (Testo stampato), 2024

• DOI för Comparison of quantitative [11C]PE2I brain PET studies between an integrated PET/MR and a stand-alone PET system
• Ladda ner fulltext (pdf) av Comparison of quantitative [11C]PE2I brain PET studies between an integrated PET/MR and a stand-alone PET system

Levels of inflammatory cytokines MCP-1, CCL4, and PD-L1 in CSF differentiate idiopathic normal pressure hydrocephalus from neurodegenerative diseases

Braun, Madelen; Boström, Gustaf; Ingelsson, Martin; Kilander, Lena et al.

Ingår i Fluids and Barriers of the CNS, 2023

• DOI för Levels of inflammatory cytokines MCP-1, CCL4, and PD-L1 in CSF differentiate idiopathic normal pressure hydrocephalus from neurodegenerative diseases
• Ladda ner fulltext (pdf) av Levels of inflammatory cytokines MCP-1, CCL4, and PD-L1 in CSF differentiate idiopathic normal pressure hydrocephalus from neurodegenerative diseases

Patients accept therapy using embryonic stem cells for Parkinson's disease: a discrete choice experiment

Schölin Bywall, Karin; Drevin, Jennifer; Groothuis-Oudshoorn, Catharina; Veldwijk, Jorien et al.

Ingår i BMC Medical Ethics, 2023

• DOI för Patients accept therapy using embryonic stem cells for Parkinson's disease: a discrete choice experiment
• Ladda ner fulltext (pdf) av Patients accept therapy using embryonic stem cells for Parkinson's disease: a discrete choice experiment

The Impact of COVID-19 on Parkinson's Disease: A Case-Controlled Registry and Questionnaire Study on Clinical Markers and Patients' Perceptions

Weber, Gustav Cedergren; Timpka, Jonathan; Bergquist, Filip; Backstrom, David et al.

Ingår i Acta Neurologica Scandinavica, 2023

• DOI för The Impact of COVID-19 on Parkinson's Disease: A Case-Controlled Registry and Questionnaire Study on Clinical Markers and Patients' Perceptions
• Ladda ner fulltext (pdf) av The Impact of COVID-19 on Parkinson's Disease: A Case-Controlled Registry and Questionnaire Study on Clinical Markers and Patients' Perceptions

Phosphorylated α-synuclein in skin Schwann cells: a new biomarker for multiple system atrophy

Donadio, Vincenzo; Incensi, Alex; Rizzo, Giovanni; Westermark, Gunilla T. et al.

Ingår i Brain, s. 1065-1074, 2023

• DOI för Phosphorylated α-synuclein in skin Schwann cells: a new biomarker for multiple system atrophy

Higher levels of neurofilament light chain and total tau in CSF are associated with negative outcome after shunt surgery in patients with normal pressure hydrocephalus

Braun, Madelen; Bjurnemark, Caroline; Seo, Woosung; Freyhult, Eva et al.

Ingår i Fluids and Barriers of the CNS, 2022

• DOI för Higher levels of neurofilament light chain and total tau in CSF are associated with negative outcome after shunt surgery in patients with normal pressure hydrocephalus
• Ladda ner fulltext (pdf) av Higher levels of neurofilament light chain and total tau in CSF are associated with negative outcome after shunt surgery in patients with normal pressure hydrocephalus

Toward Improved Treatment and Empowerment of Individuals With Parkinson Disease: Design and Evaluation of an Internet of Things System

Karni, Liran; Jusufi, Ilir; Nyholm, Dag; Klein, Gunnar Oskar et al.

Ingår i JMIR Formative Research, 2022

• DOI för Toward Improved Treatment and Empowerment of Individuals With Parkinson Disease: Design and Evaluation of an Internet of Things System
• Ladda ner fulltext (pdf) av Toward Improved Treatment and Empowerment of Individuals With Parkinson Disease: Design and Evaluation of an Internet of Things System

Optimizing Treatment of Parkinson's Disease

Nyholm, Dag; Bergquist, Filip

Ingår i Journal of Personalized Medicine, 2022

• DOI för Optimizing Treatment of Parkinson's Disease
• Ladda ner fulltext (pdf) av Optimizing Treatment of Parkinson's Disease

Patients' views on using human embryonic stem cells to treat Parkinson's disease: an interview study

Drevin, Jennifer; Nyholm, Dag; Widner, Håkan; Van Vliet, Trinette et al.

Ingår i BMC Medical Ethics, 2022

• DOI för Patients' views on using human embryonic stem cells to treat Parkinson's disease: an interview study
• Ladda ner fulltext (pdf) av Patients' views on using human embryonic stem cells to treat Parkinson's disease: an interview study

Attitudes and values among the Swedish general public to using human embryonic stem cells for medical treatment

Grauman, Åsa; Hansson, Mats G.; Nyholm, Dag; Jiltsova, Elena et al.

Ingår i BMC Medical Ethics, 2022

• DOI för Attitudes and values among the Swedish general public to using human embryonic stem cells for medical treatment
• Ladda ner fulltext (pdf) av Attitudes and values among the Swedish general public to using human embryonic stem cells for medical treatment

Midbrain area and the hummingbird sign from brain MRI in progressive supranuclear palsy and idiopathic normal pressure hydrocephalus

Virhammar, Johan; Blohmé, Harald; Nyholm, Dag; Georgiopoulos, Charalampos et al.

Ingår i Journal of Neuroimaging, s. 90-96, 2022

• DOI för Midbrain area and the hummingbird sign from brain MRI in progressive supranuclear palsy and idiopathic normal pressure hydrocephalus
• Ladda ner fulltext (pdf) av Midbrain area and the hummingbird sign from brain MRI in progressive supranuclear palsy and idiopathic normal pressure hydrocephalus

Composite attenuation correction method using a ⁶⁸Ge-transmission multi-atlas for quantitative brain PET/MR.

Sousa, Joao M.; Appel, Lieuwe; Engström, Mathias; Papadimitriou, Stergios et al.

Ingår i Physica medica (Testo stampato), s. 36-43, 2022

• DOI för Composite attenuation correction method using a ⁶⁸Ge-transmission multi-atlas for quantitative brain PET/MR.
• Ladda ner fulltext (pdf) av Composite attenuation correction method using a ⁶⁸Ge-transmission multi-atlas for quantitative brain PET/MR.

Trial of Deferiprone in Parkinson’s Disease

Devos, David; Labreuche, Julien; Rascol, Olivier; Corvol, Jean-Christophe et al.

Ingår i New England Journal of Medicine, s. 2045-2055, 2022

• DOI för Trial of Deferiprone in Parkinson’s Disease

Pharmacokinetics of Intravenously (DIZ101), Subcutaneously (DIZ102), and Intestinally (LCIG) Infused Levodopa in Advanced Parkinson Disease

Bergquist, Filip; Ehrnebo, Mats; Nyholm, Dag; Johansson, Anders et al.

Ingår i Neurology, 2022

• DOI för Pharmacokinetics of Intravenously (DIZ101), Subcutaneously (DIZ102), and Intestinally (LCIG) Infused Levodopa in Advanced Parkinson Disease
• Ladda ner fulltext (pdf) av Pharmacokinetics of Intravenously (DIZ101), Subcutaneously (DIZ102), and Intestinally (LCIG) Infused Levodopa in Advanced Parkinson Disease

Close relationships in Parkinson ' s disease patients with device-aided therapy

Scharfenort, Monica; Timpka, Jonathan; Sahlström, Thomas; Henriksen, Tove et al.

Ingår i Brain and Behavior, 2021

• DOI för Close relationships in Parkinson ' s disease patients with device-aided therapy
• Ladda ner fulltext (pdf) av Close relationships in Parkinson ' s disease patients with device-aided therapy

Pain, disease severity and associations with individual quality of life in patients with motor neuron diseases

Åkerblom, Ylva; Zetterberg, Lena; Jakobsson Larsson, Birgitta; Nyholm, Dag et al.

Ingår i BMC Palliative Care, 2021

• DOI för Pain, disease severity and associations with individual quality of life in patients with motor neuron diseases
• Ladda ner fulltext (pdf) av Pain, disease severity and associations with individual quality of life in patients with motor neuron diseases

Imaging features associated with idiopathic normal pressure hydrocephalus have high specificity even when comparing with vascular dementia and atypical parkinsonism

Fällmar, David; Andersson, Oliver; Kilander, Lena; Löwenmark, Malin et al.

Ingår i Fluids and Barriers of the CNS, 2021

• DOI för Imaging features associated with idiopathic normal pressure hydrocephalus have high specificity even when comparing with vascular dementia and atypical parkinsonism
• Ladda ner fulltext (pdf) av Imaging features associated with idiopathic normal pressure hydrocephalus have high specificity even when comparing with vascular dementia and atypical parkinsonism

Proenkephalin Decreases in Cerebrospinal Fluid with Symptom Progression of Huntington's Disease

Niemelä, Valter; Landtblom, Anne-Marie; Nyholm, Dag; Kneider, Maria et al.

Ingår i Movement Disorders, s. 481-491, 2021

• DOI för Proenkephalin Decreases in Cerebrospinal Fluid with Symptom Progression of Huntington's Disease
• Ladda ner fulltext (pdf) av Proenkephalin Decreases in Cerebrospinal Fluid with Symptom Progression of Huntington's Disease

Personalized Medicine Approach in Treating Parkinson's Disease, Using Oral Administration of Levodopa/Carbidopa Microtablets in Clinical Practice

Gretarsdottir, Helga Maria; Widman, Erik; Johansson, Anders; Nyholm, Dag

Ingår i Journal of Personalized Medicine, 2021

• DOI för Personalized Medicine Approach in Treating Parkinson's Disease, Using Oral Administration of Levodopa/Carbidopa Microtablets in Clinical Practice
• Ladda ner fulltext (pdf) av Personalized Medicine Approach in Treating Parkinson's Disease, Using Oral Administration of Levodopa/Carbidopa Microtablets in Clinical Practice

Initial Experience of the Levodopa–Entacapone–Carbidopa Intestinal Gel in Clinical Practice

Öthman, Mezin; Widman, Erik; Nygren, Ingela; Nyholm, Dag

Ingår i Journal of Personalized Medicine, 2021

• DOI för Initial Experience of the Levodopa–Entacapone–Carbidopa Intestinal Gel in Clinical Practice
• Ladda ner fulltext (pdf) av Initial Experience of the Levodopa–Entacapone–Carbidopa Intestinal Gel in Clinical Practice

An updated calculator for determining levodopa-equivalent dose

Nyholm, D.; Jost, W. H.

Ingår i Neurological Research and Practice, 2021

• DOI för An updated calculator for determining levodopa-equivalent dose
• Ladda ner fulltext (pdf) av An updated calculator for determining levodopa-equivalent dose

Parkinsons sjukdom – heterogen och komplex i sitt kliniska uttryck: Individuella kombinationer av symtom som ändrar sig över tid kräver behandlingsjusteringar och anpassningar: [Parkinson's disease - heterogeneous and complex in its clinical presentation]

Bergquist, Filip; Johansson, Anders; Dizdar, Nil; Widner, Håkan et al.

Ingår i Läkartidningen, 2020

A survey of lifestyle factors in dystonia.

Söderlund, Jacob; Nyholm, Dag

Ingår i Brain and Behavior, 2020

• DOI för A survey of lifestyle factors in dystonia.
• Ladda ner fulltext (pdf) av A survey of lifestyle factors in dystonia.

A Phase 2a Trial Investigating the Safety and Tolerability of the Novel Cortical Enhancer IRL752 in Parkinson's Disease Dementia

Svenningsson, Per; Odin, Per; Dizdar, Nil; Johansson, Anders et al.

Ingår i Movement Disorders, s. 1046-1054, 2020

• DOI för A Phase 2a Trial Investigating the Safety and Tolerability of the Novel Cortical Enhancer IRL752 in Parkinson's Disease Dementia

Population pharmacokinetics of levodopa gel infusion in Parkinson's disease: effects of entacapone infusion and genetic polymorphism

Senek, Marina; Nyholm, Dag; Nielsen, Elisabet I.

Ingår i Scientific Reports, 2020

• DOI för Population pharmacokinetics of levodopa gel infusion in Parkinson's disease: effects of entacapone infusion and genetic polymorphism
• Ladda ner fulltext (pdf) av Population pharmacokinetics of levodopa gel infusion in Parkinson's disease: effects of entacapone infusion and genetic polymorphism

Accuracy and precision of zero-echo-time, single- and multi-atlas attenuation correction for dynamic [¹¹C]PE2I PET-MR brain imaging

Sousa, João M.; Appel, Lieuwe; Merida, Inés; Heckemann, Rolf A. et al.

Ingår i EJNMMI Physics, 2020

• DOI för Accuracy and precision of zero-echo-time, single- and multi-atlas attenuation correction for dynamic [¹¹C]PE2I PET-MR brain imaging
• Ladda ner fulltext (pdf) av Accuracy and precision of zero-echo-time, single- and multi-atlas attenuation correction for dynamic [¹¹C]PE2I PET-MR brain imaging

Everyday Occupations and Other Factors in Relation to Mental Well-Being Among Persons With Advanced Parkinson's Disease

Hultqvist, J; Sahlstrom, T; Timpka, J; Henriksen, T et al.

Ingår i Occupational Therapy in Health Care, s. 1-18, 2020

• DOI för Everyday Occupations and Other Factors in Relation to Mental Well-Being Among Persons With Advanced Parkinson's Disease

Real-Life Use of Levodopa/Carbidopa Intestinal Gel in Parkinson's Disease According to Analysis of Pump Data

Nyholm, Dag; Adnan, Malak; Senek, Marina

Ingår i Journal of Parkinson's Disease, s. 1529-1534, 2020

• DOI för Real-Life Use of Levodopa/Carbidopa Intestinal Gel in Parkinson's Disease According to Analysis of Pump Data

A multiple motion sensors index for motor state quantification in Parkinson's disease

Aghanavesi, Somayeh; Westin, Jerker; Bergquist, Filip; Nyholm, Dag et al.

Ingår i Computer Methods and Programs in Biomedicine, 2020

• DOI för A multiple motion sensors index for motor state quantification in Parkinson's disease

Motion Sensor-Based Assessment of Parkinson's Disease Motor Symptoms During Leg Agility Tests: Results From Levodopa Challenge

Aghanavesi, S; Bergquist, F; Nyholm, Dag; Senek, Marina et al.

Ingår i IEEE journal of biomedical and health informatics, s. 111-119, 2020

• DOI för Motion Sensor-Based Assessment of Parkinson's Disease Motor Symptoms During Leg Agility Tests: Results From Levodopa Challenge

Alterations in the tyrosine and phenylalanine pathways revealed by biochemical profiling in cerebrospinal fluid of Huntington's disease subjects

Herman, Stephanie; Niemelä, Valter; Emami Khoonsari, Payam; Sundblom, Jimmy et al.

Ingår i Scientific Reports, 2019

• DOI för Alterations in the tyrosine and phenylalanine pathways revealed by biochemical profiling in cerebrospinal fluid of Huntington's disease subjects
• Ladda ner fulltext (pdf) av Alterations in the tyrosine and phenylalanine pathways revealed by biochemical profiling in cerebrospinal fluid of Huntington's disease subjects

Evaluation of a sensor algorithm for motor state rating in Parkinson's disease

Johansson, Dongni; Thomas, Ilias; Ericsson, Anders; Johansson, Anders et al.

Ingår i Parkinsonism & Related Disorders, s. 112-117, 2019

• DOI för Evaluation of a sensor algorithm for motor state rating in Parkinson's disease

Sensor-based algorithmic dosing suggestions for oral administration of levodopa/carbidopa microtablets for Parkinson's disease: a first experience.

Thomas, I; Alam, M; Bergquist, F; Johansson, D et al.

Ingår i Journal of Neurology, s. 651-658, 2019

• DOI för Sensor-based algorithmic dosing suggestions for oral administration of levodopa/carbidopa microtablets for Parkinson's disease: a first experience.
• Ladda ner fulltext (pdf) av Sensor-based algorithmic dosing suggestions for oral administration of levodopa/carbidopa microtablets for Parkinson's disease: a first experience.

The effect of continuous levodopa treatment during the afternoon hours

Thomas, Ilias; Memedi, Mevludin; Westin, Jerker; Nyholm, Dag

Ingår i Acta Neurologica Scandinavica, s. 70-75, 2019

• DOI för The effect of continuous levodopa treatment during the afternoon hours

Evaluation of zero-echo-time attenuation correction for integrated PET/MR brain imaging-comparison to head atlas and ⁶⁸Ge-transmission-based attenuation correction

Sousa, João M.; Appel, Lieuwe; Engström, Mathias; Papadimitriou, Stergios et al.

Ingår i EJNMMI Physics, 2018

• DOI för Evaluation of zero-echo-time attenuation correction for integrated PET/MR brain imaging-comparison to head atlas and ⁶⁸Ge-transmission-based attenuation correction
• Ladda ner fulltext (pdf) av Evaluation of zero-echo-time attenuation correction for integrated PET/MR brain imaging-comparison to head atlas and ⁶⁸Ge-transmission-based attenuation correction

Safety and tolerability of IRL790 in Parkinson’s disease with levodopa-induced dyskinesia—a phase 1b trial

Svenningsson, P; Johansson, A; Nyholm, Dag; Tsitsi, P et al.

Ingår i npj Parkinson's Disease, 2018

• DOI för Safety and tolerability of IRL790 in Parkinson’s disease with levodopa-induced dyskinesia—a phase 1b trial
• Ladda ner fulltext (pdf) av Safety and tolerability of IRL790 in Parkinson’s disease with levodopa-induced dyskinesia—a phase 1b trial

Differential diagnosis of patients with parkinsonian syndrome using multilinear regression to disease-specific C-11-PE2I-PET templates and classification tree learning

Lubberink, Mark; Widström, Charles; Jonasson, My; Appel, Lieuwe et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2018

Population pharmacokinetics of levodopa/carbidopa microtablets in healthy subjects and Parkinson’s disease patients

Senek, Marina; Nyholm, Dag; Nielsen, Elisabet I.

Ingår i European Journal of Clinical Pharmacology, s. 1299-1307, 2018

• DOI för Population pharmacokinetics of levodopa/carbidopa microtablets in healthy subjects and Parkinson’s disease patients
• Ladda ner fulltext (pdf) av Population pharmacokinetics of levodopa/carbidopa microtablets in healthy subjects and Parkinson’s disease patients

A Treatment-Response Index From Wearable Sensors for Quantifying Parkinson's Disease Motor States

Thomas, Ilias; Westin, Jerker; Alam, Moudud; Bergquist, Filip et al.

Ingår i IEEE journal of biomedical and health informatics, s. 1341-1349, 2018

• DOI för A Treatment-Response Index From Wearable Sensors for Quantifying Parkinson's Disease Motor States

Workforce participation and activities in Parkinson's disease patients receiving device-aided therapy

Sahlstrom, T.; Eklund, M.; Timpka, J.; Henriksen, T. et al.

Ingår i Acta Neurologica Scandinavica, s. 78-84, 2018

• DOI för Workforce participation and activities in Parkinson's disease patients receiving device-aided therapy

Individualization of levodopa treatment using a microtablet dispenser and ambulatory accelerometry

Johansson, Dongni; Ericsson, Anders; Johansson, Anders; Medvedev, Alexander et al.

Ingår i CNS Neuroscience & Therapeutics, s. 439-447, 2018

• DOI för Individualization of levodopa treatment using a microtablet dispenser and ambulatory accelerometry

Individual dose-response models for levodopa infusion dose optimization

Thomas, Ilias; Alam, Moudud; Nyholm, Dag; Senek, Marina et al.

Ingår i International Journal of Medical Informatics, s. 137-142, 2018

• DOI för Individual dose-response models for levodopa infusion dose optimization

A randomized, double-blind, placebo-controlled trial of camicinal in Parkinson's disease.

Marrinan, Sarah L; Otiker, Tal; Vasist, Lakshmi S; Gibson, Rachel A et al.

Ingår i Movement Disorders, s. 329-332, 2018

• DOI för A randomized, double-blind, placebo-controlled trial of camicinal in Parkinson's disease.
• Ladda ner fulltext (pdf) av A randomized, double-blind, placebo-controlled trial of camicinal in Parkinson's disease.

Verification of a Method for Measuring Parkinson's Disease Related Temporal Irregularity in Spiral Drawings

Aghanavesi, Somayeh; Memedi, Mevludin; Dougherty, Mark; Nyholm, Dag et al.

Ingår i Sensors, 2017

• DOI för Verification of a Method for Measuring Parkinson's Disease Related Temporal Irregularity in Spiral Drawings
• Ladda ner fulltext (pdf) av Verification of a Method for Measuring Parkinson's Disease Related Temporal Irregularity in Spiral Drawings

First clinical experience with levodopa/carbidopa microtablets in Parkinson’s disease

Senek, Marina; Hellström, Malin; Albo, Jaan; Svenningsson, Per et al.

Ingår i Acta Neurologica Scandinavica, s. 727-731, 2017

• DOI för First clinical experience with levodopa/carbidopa microtablets in Parkinson’s disease

Levodopa/carbidopa microtablets in Parkinson’s disease: A study of pharmacokinetics and blinded motor assessment

Senek, Marina; Aquilonius, Sten-Magnus; Askmark, Håkan; Bergquist, Filip et al.

Ingår i European Journal of Clinical Pharmacology, s. 563-571, 2017

• DOI för Levodopa/carbidopa microtablets in Parkinson’s disease: A study of pharmacokinetics and blinded motor assessment

Levodopa-entacapone-carbidopa intestinal gel in Parkinson's disease: A randomized crossover study

Senek, Marina; Nielsen, Elisabet I.; Nyholm, Dag

Ingår i Movement Disorders, s. 283-286, 2017

• DOI för Levodopa-entacapone-carbidopa intestinal gel in Parkinson's disease: A randomized crossover study

Initiation of Levodopa-Carbidopa Intestinal Gel Infusion Using Telemedicine (Video Communication System) Facilitates Efficient and Well-Accepted Home Titration in Patients with Advanced Parkinson's Disease

Willows, Thomas; Dizdar, Nil; Nyholm, Dag; Widner, Hakan et al.

Ingår i Journal of Parkinson's Disease, s. 719-728, 2017

• DOI för Initiation of Levodopa-Carbidopa Intestinal Gel Infusion Using Telemedicine (Video Communication System) Facilitates Efficient and Well-Accepted Home Titration in Patients with Advanced Parkinson's Disease
• Ladda ner fulltext (pdf) av Initiation of Levodopa-Carbidopa Intestinal Gel Infusion Using Telemedicine (Video Communication System) Facilitates Efficient and Well-Accepted Home Titration in Patients with Advanced Parkinson's Disease

Development of a clinically feasible [11C]PE2I PET method for differential diagnosis of parkinsonism using reduced scan duration and automated reference region extraction.

Jonasson, My; Appel, Lieuwe; Danfors, Torsten; Nyholm, Dag et al.

Ingår i American Journal of Nuclear Medicine and Molecular Imaging, s. 263-274, 2017

• Ladda ner fulltext (pdf) av Development of a clinically feasible [11C]PE2I PET method for differential diagnosis of parkinsonism using reduced scan duration and automated reference region extraction.

Feasibility of spirography features for objective assessment of motor function in Parkinson's disease

Sadikov, Aleksander; Groznik, Vida; Mozina, Martin; Zabkar, Jure et al.

Ingår i Artificial Intelligence in Medicine, s. 54-62, 2017

• DOI för Feasibility of spirography features for objective assessment of motor function in Parkinson's disease

Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinson's disease: An open-label prospective observational study of effectiveness, tolerability and healthcare costs

Pålhagen, Sven E.; Sydow, Olof; Johansson, Anders; Nyholm, Dag et al.

Ingår i Parkinsonism & Related Disorders, s. 17-23, 2016

• DOI för Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinson's disease: An open-label prospective observational study of effectiveness, tolerability and healthcare costs
• Ladda ner fulltext (pdf) av Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinson's disease: An open-label prospective observational study of effectiveness, tolerability and healthcare costs

Validation of Zero-Echo Time PET-MR against stand-alone PET using dynamic dopamine transporter imaging

Sousa, Joao M.; Appel, Lieuwe; Papadimitriou, S.; Nyholm, Dag et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2016

Transcutaneous port for levodopa/carbidopa intestinal gel administration in Parkinson's disease

van Laar, T; Nyholm, Dag; Nyman, Rickard

Ingår i Acta Neurologica Scandinavica, s. 208-215, 2016

• DOI för Transcutaneous port for levodopa/carbidopa intestinal gel administration in Parkinson's disease

Authors' Reply to Lambarth: "Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review"

Wirdefeldt, Karin; Odin, Per; Nyholm, Dag

Ingår i CNS Drugs, s. 1009-1010, 2016

• DOI för Authors' Reply to Lambarth: "Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review"

Automatic Spiral Analysis for Objective Assessment of Motor Symptoms in Parkinson's Disease

Memedi, Mevludin; Sadikov, Aleksander; Groznik, Vida; Zabkar, Jure et al.

Ingår i Sensors, s. 23727-23744, 2015

• DOI för Automatic Spiral Analysis for Objective Assessment of Motor Symptoms in Parkinson's Disease
• Ladda ner fulltext (pdf) av Automatic Spiral Analysis for Objective Assessment of Motor Symptoms in Parkinson's Disease

A Comparison of Botox 100 U/mL and Dysport 100 U/mL Using Dose Conversion Ratio 1: 3 and 1: 1.7 in the Treatment of Cervical Dystonia: A Double-Blind, Randomized, Crossover Trial

Rystedt, Alma; Zetterberg, Lena; Burman, Joachim; Nyholm, Dag et al.

Ingår i Clinical neuropharmacology, s. 170-176, 2015

• DOI för A Comparison of Botox 100 U/mL and Dysport 100 U/mL Using Dose Conversion Ratio 1: 3 and 1: 1.7 in the Treatment of Cervical Dystonia: A Double-Blind, Randomized, Crossover Trial

Use of C-11-PE2I PET in Differential Diagnosis of Parkinsonian Disorders

Appel, Lieuwe; Jonasson, My; Danfors, Torsten; Nyholm, Dag et al.

Ingår i Journal of Nuclear Medicine, s. 234-242, 2015

• DOI för Use of C-11-PE2I PET in Differential Diagnosis of Parkinsonian Disorders

Validity and Responsiveness of At-Home Touch Screen Assessments in Advanced Parkinson's Disease

Memedi, Mevludin; Nyholm, Dag; Johansson, Anders; Palhagen, Sven et al.

Ingår i IEEE journal of biomedical and health informatics, s. 1829-1834, 2015

• DOI för Validity and Responsiveness of At-Home Touch Screen Assessments in Advanced Parkinson's Disease
• Ladda ner fulltext (pdf) av Validity and Responsiveness of At-Home Touch Screen Assessments in Advanced Parkinson's Disease

Continuous drug delivery in Parkinson's disease

Senek, Marina; Nyholm, Dag

Ingår i CNS Drugs, s. 19-27, 2014

• DOI för Continuous drug delivery in Parkinson's disease

A computer vision framework for finger-tapping evaluation in Parkinson's disease

Khan, Taha; Nyholm, Dag; Westin, Jerker; Dougherty, Mark

Ingår i Artificial Intelligence in Medicine, s. 27-40, 2014

• DOI för A computer vision framework for finger-tapping evaluation in Parkinson's disease

Levodopa Fractionation in Parkinson's Disease

Nyholm, Dag; Stepien, Victoria

Ingår i Journal of Parkinson's Disease, s. 89-96, 2014

• DOI för Levodopa Fractionation in Parkinson's Disease

Pharmacokinetics of Levodopa, Carbidopa, and 3-O-Methyldopa Following 16-hour Jejunal Infusion of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease Patients

Nyholm, Dag; Odin, Per; Johansson, Anders; Chatamra, Krai et al.

Ingår i AAPS Journal, s. 316-323, 2013

• DOI för Pharmacokinetics of Levodopa, Carbidopa, and 3-O-Methyldopa Following 16-hour Jejunal Infusion of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease Patients

Automatic and Objective Assessment of Alternating Tapping Performance in Parkinson's Disease

Memedi, Mevludin; Khan, Taha; Grenholm, Peter; Nyholm, Dag et al.

Ingår i Sensors, s. 16965-16984, 2013

• DOI för Automatic and Objective Assessment of Alternating Tapping Performance in Parkinson's Disease

Computer Vision Methods for Parkinsonian Gait Analysis: A Review onPatents

Khan, Taha; Grenholm, Peter; Nyholm, Dag

Ingår i Recent Patents on Biomedical Engineering, s. 97-108, 2013

• DOI för Computer Vision Methods for Parkinsonian Gait Analysis: A Review onPatents

Validation of parametric methods for [(11)C]PE2I positron emission tomography

Jonasson, My; Appel, Lieuwe; Engman, Jonas; Frick, Andreas et al.

Ingår i NeuroImage, s. 172-178, 2013

• DOI för Validation of parametric methods for [(11)C]PE2I positron emission tomography

Frequent administration of levodopa/carbidopa microtablets vs levodopa/carbidopa/entacapone in healthy volunteers

Nyholm, Dag; Ehrnebo, M; Lewander, Tommy; Trolin, C G et al.

Ingår i Acta Neurologica Scandinavica, s. 124-132, 2013

• DOI för Frequent administration of levodopa/carbidopa microtablets vs levodopa/carbidopa/entacapone in healthy volunteers

Spiral drawing during self-rated dyskinesia is more impaired than during self-rated off.

Memedi, Mevludin; Westin, Jerker; Nyholm, Dag

Ingår i Parkinsonism & Related Disorders, s. 553-556, 2013

• DOI för Spiral drawing during self-rated dyskinesia is more impaired than during self-rated off.

Motor fluctuations and Helicobacter pylori in Parkinson's disease

Rahne, Karl-Erik; Tagesson, Carl; Nyholm, Dag

Ingår i Journal of Neurology, s. 2974-2980, 2013

• DOI för Motor fluctuations and Helicobacter pylori in Parkinson's disease

Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based review

Volkmann, J; Albanese, A; Antonini, A; Chaudhuri, KR et al.

Ingår i Journal of Neurology, s. 2701-2714, 2013

• DOI för Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based review
• Ladda ner fulltext (pdf) av Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based review

Combined fine-motor tests and self-assessments for remote detection of motor fluctuations

Memedi, Mevludin; Nyholm, Dag; Westin, Jerker

Ingår i Recent Patents on Biomedical Engineering, s. 127-135, 2013

• DOI för Combined fine-motor tests and self-assessments for remote detection of motor fluctuations

Levodopa/carbidopa intestinal gel infusion long-term therapy in advanced Parkinson's disease

Nyholm, Dag; Klangemo, K; Johansson, Anders

Ingår i European Journal of Neurology, s. 1079-1085, 2012

• DOI för Levodopa/carbidopa intestinal gel infusion long-term therapy in advanced Parkinson's disease

Validation of a home environment test battery for supporting assessments in advanced Parkinson’s disease

Westin, Jerker; Schiavella, Mauro; Memedi, Mevludin; Nyholm, Dag et al.

Ingår i Neurological Sciences, s. 831-838, 2012

• DOI för Validation of a home environment test battery for supporting assessments in advanced Parkinson’s disease

Levodopa infusion combined with entacapone or tolcapone in Parkinson disease: a pilot trial

Nyholm, Dag; Johansson, Anders; Lennernäs, Hans; Askmark, Håkan

Ingår i European Journal of Neurology, s. 820-826, 2012

• DOI för Levodopa infusion combined with entacapone or tolcapone in Parkinson disease: a pilot trial

Levodopa fractionation in Parkinson's disease: half of the patients use more than four daily doses after 5 years

Nyholm, Dag; Stepien, V.

Ingår i European Journal of Neurology, s. 24-24, 2012

• DOI för Levodopa fractionation in Parkinson's disease: half of the patients use more than four daily doses after 5 years

Clinical Experience of Dose Conversion Ratios Between 2 Botulinum Toxin Products in the Treatment of Cervical Dystonia

Rystedt, Alma; Nyholm, Dag; Naver, Hans

Ingår i Clinical neuropharmacology, s. 278-282, 2012

• DOI för Clinical Experience of Dose Conversion Ratios Between 2 Botulinum Toxin Products in the Treatment of Cervical Dystonia

Parametric methods for [¹¹C]PE2I positron emission tomography

Jonasson, My; Appel, Lieuwe; Engman, Jonas; Frick, Andreas et al.

Ingår i Journal of Cerebral Blood Flow and Metabolism, 2012

• DOI för Parametric methods for [¹¹C]PE2I positron emission tomography

Long-term 24-h levodopa/carbidopa gel infusion in Parkinson's disease

Busk, Karin; Nyholm, Dag

Ingår i Parkinsonism & Related Disorders, s. 1000-1001, 2012

• DOI för Long-term 24-h levodopa/carbidopa gel infusion in Parkinson's disease

Interim analysis of long-term intraduodenal levodopa infusion in advanced Parkinson disease

Pålhagen, S E; Dizdar, N; Hauge, T; Holmberg, B et al.

Ingår i Acta Neurologica Scandinavica, 2012

• DOI för Interim analysis of long-term intraduodenal levodopa infusion in advanced Parkinson disease

Pharmacokinetics of levodopa/carbidopa microtablets versus levodopa/benserazide and levodopa/carbidopa in healthy volunteers

Nyholm, Dag; Lewander, Tommy; Gomes-Trolin, Cecilia; Bäckström, Tobias et al.

Ingår i Clinical neuropharmacology, s. 111-117, 2012

• DOI för Pharmacokinetics of levodopa/carbidopa microtablets versus levodopa/benserazide and levodopa/carbidopa in healthy volunteers

Treatment of advanced Parkinson's disease with levodopa/carbidopa intestinal gel is associated with improvements in Hoehn and Yahr stage

Munro Neville, A; Parsons, Richard W; Askmark, Håkan; Nyholm, Dag

Ingår i Parkinsonism & Related Disorders, s. 686-687, 2012

• DOI för Treatment of advanced Parkinson's disease with levodopa/carbidopa intestinal gel is associated with improvements in Hoehn and Yahr stage

Duodopa(®) treatment for advanced Parkinson's disease: A review of efficacy and safety

Nyholm, Dag

Ingår i Parkinsonism & Related Disorders, s. 916-929, 2012

• DOI för Duodopa(®) treatment for advanced Parkinson's disease: A review of efficacy and safety

Update on levodopa/carbidopa intestinal gel infusion

Nyholm, Dag

Ingår i European Neurological Review, s. 13-16, 2012

Continuous delivery of energy or L-dopa: Identifying advantages and limitations of DBS and levodopa-carbidopa intestinal gel in ansence of head-to-head comparisons

Johansson, Anders; Nyholm, Dag

Ingår i Basal Ganglia, s. 221-226, 2012

• DOI för Continuous delivery of energy or L-dopa: Identifying advantages and limitations of DBS and levodopa-carbidopa intestinal gel in ansence of head-to-head comparisons

A pharmacokinetic-pharmacodynamic model for duodenal levodopa infusion

Westin, Jerker; Nyholm, Dag; Pålhagen, Sven; Willows, Thomas et al.

Ingår i Clinical neuropharmacology, s. 61-65, 2011

• DOI för A pharmacokinetic-pharmacodynamic model for duodenal levodopa infusion

Stalevo reduction in dyskinesia evaluation in Parkinson's disease results were expected from a pharmacokinetic viewpoint

Nyholm, Dag; Askmark, Håkan; Aquilonius, Sten-Magnus

Ingår i Annals of Neurology, s. 424-424, 2011

• DOI för Stalevo reduction in dyskinesia evaluation in Parkinson's disease results were expected from a pharmacokinetic viewpoint

Long-term efficacy and safety with continuous dopaminergic stimulation pump treatments in Parkinson's disease

Busk, Karin; Johansson, Anders; Nyholm, Dag

Ingår i European Neurological Review, s. 156-160, 2011

A web application for follow-up of results from a mobile device test battery for Parkinson’s disease patients

Memedi, Mevludin; Westin, Jerker; Nyholm, Dag; Dougherty, Mark et al.

Ingår i Computer Methods and Programs in Biomedicine, s. 219-226, 2011

• DOI för A web application for follow-up of results from a mobile device test battery for Parkinson’s disease patients

Clinical, neuroimaging and neurophysiological features in addicts with manganese-ephedrone exposure

Sikk, K; Taba, P; Haldre, S; Bergquist, Jonas et al.

Ingår i Acta Neurologica Scandinavica, s. 237-243, 2010

• DOI för Clinical, neuroimaging and neurophysiological features in addicts with manganese-ephedrone exposure

A home environment test battery for status assessment in patients with advanced Parkinson's disease

Westin, Jerker; Dougherty, Mark; Nyholm, Dag; Groth, Torgny

Ingår i Computer Methods and Programs in Biomedicine, s. 27-35, 2010

• DOI för A home environment test battery for status assessment in patients with advanced Parkinson's disease

Large differences in levodopa dose requirement in Parkinson's disease: men use higher doses than women

Nyholm, Dag; Karlsson, E.; Lundberg, M; Askmark, Håkan

Ingår i European Journal of Neurology, s. 260-266, 2010

• DOI för Large differences in levodopa dose requirement in Parkinson's disease: men use higher doses than women

A new computer method for assessing drawing impairment in Parkinson's disease

Westin, Jerker; Ghiamati, Samira; Memedi, Mevludin; Nyholm, Dag et al.

Ingår i Journal of Neuroscience Methods, s. 143-148, 2010

• DOI för A new computer method for assessing drawing impairment in Parkinson's disease

Circadian rhythmicity in levodopa pharmacokinetics in patients with Parkinson disease

Nyholm, Dag; Lennernäs, Hans; Johansson, Anders; Estrada, Matias et al.

Ingår i Clinical neuropharmacology, s. 181-185, 2010

• DOI för Circadian rhythmicity in levodopa pharmacokinetics in patients with Parkinson disease

Patient-Perceived Retrospective Outcome of Duodenal Levodopa Infusion in Advanced Parkinson´s Disease

Scott, Berit; Nyholm, Dag

Ingår i European Neurological Journal, s. 1-8, 2010

Short-Term Cost and Health Consequences of Duodenal Levodopa Infusion in Advanced Parkinson's Disease in Sweden: An Exploratory Study

Kristiansen, Ivar; Bingefors, Kerstin; Nyholm, Dag; Isacson, Dag

Ingår i Applied Health Economics and Health Policy, s. 167-180, 2009

• DOI för Short-Term Cost and Health Consequences of Duodenal Levodopa Infusion in Advanced Parkinson's Disease in Sweden: An Exploratory Study

Comparison of apomorphine and levodopa infusions in four patients with Parkinson's disease with symptom fluctuations

Nyholm, Dag; Constantinescu, R; Holmberg, B; Dizdar, N et al.

Ingår i Acta Neurologica Scandinavica, s. 345-348, 2009

• DOI för Comparison of apomorphine and levodopa infusions in four patients with Parkinson's disease with symptom fluctuations

Soft tissue-anchored transcutaneous port attached to an intestinal tube for long-term gastroduodenal infusion of levodopa/carbidopa in Parkinson disease

Nyman, Rickard; Lundgren, Dan; Nyholm, Dag

Ingår i Journal of Vascular and Interventional Radiology, s. 500-505, 2009

• DOI för Soft tissue-anchored transcutaneous port attached to an intestinal tube for long-term gastroduodenal infusion of levodopa/carbidopa in Parkinson disease

Enteral Levodopa/Carbidopa infusion in advanced Parkinson disease: Long-term exposure

Nyholm, Dag; Lewander, Tommy; Johansson, Anders; LeWitt, Peter A. et al.

Ingår i Clinical neuropharmacology, s. 63-73, 2008

• DOI för Enteral Levodopa/Carbidopa infusion in advanced Parkinson disease: Long-term exposure

Neurologi i förvandling - från diagnostik till terapeutisk disciplin

Smits, Anja; Andsberg, Gunnar; Andersen, Peter M; Andersson, Magnnus et al.

Ingår i Läkartidningen, s. 2413-2416, 2008

Irreversible motor impairment in young addicts - ephedrone, manganism or both?

Sikk, Katrin; Taba, Pille; Haldre, Sulev; Bergquist, Jonas et al.

Ingår i Acta Neurologica Scandinavica, s. 385-389, 2007

• DOI för Irreversible motor impairment in young addicts - ephedrone, manganism or both?

The rationale for continuous dopaminergic stimulation in advanced Parkinson's disease

Nyholm, Dag

Ingår i Parkinsonism & Related Disorders, 2007

• DOI för The rationale for continuous dopaminergic stimulation in advanced Parkinson's disease

Long-term 24-hour duodenal infusion of levodopa: Outcome and dose requirements

Nutt, JG; Deleu, D; Hanssens, Y; Nyholm, Dag et al.

Ingår i Neurology, s. 1611-1612, 2006

• DOI för Long-term 24-hour duodenal infusion of levodopa: Outcome and dose requirements

Outcome prediction of enteral levodopa/carbidopa infusion in advanced Parkinson's disease

Westin, Jerker; Nyholm, Dag; Groth, Torgny; Dougherty, Mark et al.

Ingår i Parkinsonism & Related Disorders, s. 509-513, 2006

• DOI för Outcome prediction of enteral levodopa/carbidopa infusion in advanced Parkinson's disease

Enteral levodopa/carbidopa gel infusion for the treatment of motor fluctuations and dyskinesias in advanced Parkinson's disease

Nyholm, Dag

Ingår i Expert Review Neurotherapeutics, s. 1403-1411, 2006

Pharmacokinetic optimisation in the treatment of Parkinson's disease: an update

Nyholm, Dag

Ingår i Clinical Pharmacokinetics, s. 109-136, 2006

Infusing levodopa to stabilise blood levels

Nyholm, Dag

Ingår i EPNN Journal, s. 10-11, 2005

Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease

Nyholm, Dag; Nilsson Remahl, AIM; Dizdar, N; Constantinescu, R et al.

Ingår i Neurology, s. 216-223, 2005

Long-term 24-hour duodenal infusion of levodopa: Outcome and dose requirements

Nyholm, Dag; Jansson, Rasmus; Willows, Thomas; Nilsson Remahl, Ingela

Ingår i Neurology, s. 1506-1507, 2005

• DOI för Long-term 24-hour duodenal infusion of levodopa: Outcome and dose requirements

New developments in levodopa therapy

LeWitt, Peter; Nyholm, Dag

Ingår i Neurology, 2004

Wireless real-time electronic data capture for self-assessment of motor function and quality of life in Parkinson's disease

Nyholm, Dag; Kowalski, Jan; Aquilonius, Sten-Magnus

Ingår i Movement Disorders, s. 446-451, 2004

• DOI för Wireless real-time electronic data capture for self-assessment of motor function and quality of life in Parkinson's disease

Levodopa infusion therapy in Parkinson Disease

Nyholm, Dag; Aquilonius, Sten-Magnus

Ingår i Clinical Neuropharmacology, s. 245-256, 2004

Optimizing levodopa pharmacokinetics: intestinal infusion versus oral sustained-release tablets

Nyholm, Dag; Askmark, Håkan; Gomes-Trolin, Cecilia; Knutson, Tina et al.

Ingår i Clinical neuropharmacology, s. 156-163, 2003

An automatic dose dispenser for microtablets: A new concept for individual dosage of drugs in tablet form

Bredenberg, Susanne; Nyholm, Dag; Aquilonius, Sten-Magnus; Nyström, Christer

Ingår i International Journal of Pharmaceutics, s. 137-146, 2003

• DOI för An automatic dose dispenser for microtablets: A new concept for individual dosage of drugs in tablet form

Levodopa pharmacokinetics and motor performance during activities of daily living in patients with Parkinson's disease on individual drug combinations

Nyholm, Dag; Lennernäs, Hans; Gomes-Trolin, Cecilia; Aquilonius, Sten-Magnus

Ingår i Clinical neuropharmacology, s. 89-96, 2002

• DOI för Levodopa pharmacokinetics and motor performance during activities of daily living in patients with Parkinson's disease on individual drug combinations

Levodopa pharmacokinetics and motor performance during activities of daily living in parkinsonian patients on individual drug combinations

Nyholm, Dag; Lennernäs, Hans; Gomes-Trolin, Cecilia; Aquilonius, Sten-Magnus

Ingår i Clin Neuropharmacol, s. 89-96, 2002

Duodenal levodopa infusion in Parkinson’s disease – long-term experience

Nilsson, Dag; Nyholm, Dag; Aquilonius, Sten-Magnus

Ingår i Acta Neurol Scand, s. 343-348, 2001

Wireless real-time electronic data capture for self-assessment of motor function and quality of life in Parkinson’s disease

Nyholm, Dag; Kowalski, Jan; Aquilonius, Sten-Magnus

Levodopa-entacapone-carbidopa intestinal gel infusion in advanced Parkinson's disease: real-world experience and practical guidance

Nyholm, Dag; Jost, Wolfgang H.

Ingår i Therapeutic advances in neurological disorders, 2022

• DOI för Levodopa-entacapone-carbidopa intestinal gel infusion in advanced Parkinson's disease: real-world experience and practical guidance
• Ladda ner fulltext (pdf) av Levodopa-entacapone-carbidopa intestinal gel infusion in advanced Parkinson's disease: real-world experience and practical guidance

Effects of Helicobacter pylori on Levodopa Pharmacokinetics

Nyholm, Dag; Hellström, Per M.

Ingår i Journal of Parkinson's Disease, s. 61-69, 2021

• DOI för Effects of Helicobacter pylori on Levodopa Pharmacokinetics
• Ladda ner fulltext (pdf) av Effects of Helicobacter pylori on Levodopa Pharmacokinetics

Development of new levodopa treatment strategies in Parkinson’s disease: from bedside to bench to bedside

Aquilonius, Sten-Magnus; Nyholm, Dag

Ingår i Upsala Journal of Medical Sciences, s. 71-77, 2017

• DOI för Development of new levodopa treatment strategies in Parkinson’s disease: from bedside to bench to bedside

Levodopa-carbidopa enteral suspension in advanced Parkinson's disease: clinical evidence and experience

Virhammar, Johan; Nyholm, Dag

Ingår i Therapeutic advances in neurological disorders, s. 171-187, 2017

• DOI för Levodopa-carbidopa enteral suspension in advanced Parkinson's disease: clinical evidence and experience

Levodopa–Carbidopa Intestinal Gel in Patients with Parkinson’s Disease: A Systematic Review

Wirdefeldt, Karin; Odin, Per; Nyholm, Dag

Ingår i CNS Drugs, s. 381-404, 2016

• DOI för Levodopa–Carbidopa Intestinal Gel in Patients with Parkinson’s Disease: A Systematic Review

Complexity of Motor Response to Different Doses of Duodenal Levodopa Infusion in Parkinson Disease

Nyholm, Dag; Johansson, Anders; Aquilonius, Sten-Magnus; Hellquist, Elisabeth et al.

Ingår i Clinical neuropharmacology, s. 6-14, 2012

• DOI för Complexity of Motor Response to Different Doses of Duodenal Levodopa Infusion in Parkinson Disease

Irregular gastrointestinal drug absorption in Parkinson's disease

Nyholm, Dag; Lennernäs, Hans

Ingår i Expert Opinion on Drug Metabolism and Toxicology, s. 193-203, 2008

• DOI för Irregular gastrointestinal drug absorption in Parkinson's disease

Neurologi

Nyholm, Dag; Burman, Joachim

Liber, 2020

Neurologi

Fagius, Jan; Nyholm, Dag

Liber, 2012

Från Alzheimer till övervikt

Aquilonius, Sten-Magnus; Boman, Gunnar; Nyholm, Dag

Uppsala Publishing House, Uppsala, 2007

Pharmacotherapy for Parkinson's Disease - Observations and Innovations

Nyholm, Dag

2003

• Ladda ner fulltext (pdf) av Pharmacotherapy for Parkinson's Disease - Observations and Innovations

Funktionella neurologiska sjukdomar

Lundin, Anders; Nyholm, Dag

Ingår i Neurologi, Liber, 2020

Den neurologiska konsultationen

Burman, Joachim; Fagius, Jan; Nyholm, Dag

Ingår i Neurologi, Liber, 2020

Neurologisk symtomlära

Burman, Joachim; Fagius, Jan; Nyholm, Dag

Ingår i Neurologi, Liber, 2020

Rörelsestörningar

Bergquist, Filip; Nyholm, Dag

Ingår i Neurologi, Liber, 2020

Stochastic anomaly detection in eye-tracking data for quantification of motor symptoms in Parkinson's disease

Jansson, Daniel; Medvedev, Alexander; Axelson, Hans; Nyholm, Dag

Ingår i Signal and Image Analysis for Biomedical and Life Sciences, s. 63-82, Springer, 2015

• DOI för Stochastic anomaly detection in eye-tracking data for quantification of motor symptoms in Parkinson's disease

Den neurologiska undersökningen

Fagius, Jan; Nyholm, Dag; Aquilonius, Sten-Magnus

Ingår i Neurologi, Liber, 2012

Neurologisk symtomlära

Fagius, Jan; Nyholm, Dag

Ingår i Neurologi, Liber, 2012

Akutneurologi

Kumlien, Eva; Nyholm, Dag

Ingår i Neurologi, Liber, 2012

Rörelsestörningar

Nyholm, Dag; Aquilonius, Sten-Magnus

Ingår i Neurologi, Liber, 2012

Alternatives to oral levodopa Duodopa - continuous levodopa administration

Nyholm, Dag

Ingår i Managing advanced Parkinon's disease: the role of continuous dopaminergic stimulation, Scope Medical Ltd, London, 2007

Neural Fiber Activation in Unipolar vs Bipolar Deep Brain Stimulation

Frigge, Anna Franziska; Medvedev, Alexander; Jiltsova, Elena; Nyholm, Dag

Ingår i 2024 American Control Conference (ACC), s. 4530-4535, 2024

• DOI för Neural Fiber Activation in Unipolar vs Bipolar Deep Brain Stimulation
• Ladda ner fulltext (pdf) av Neural Fiber Activation in Unipolar vs Bipolar Deep Brain Stimulation

Unsupervised Learning from Motion Sensor Data to Assess the Condition of Patients with Parkinson's Disease

Matic, Teodora; Aghanavesi, Somayeh; Memedi, Mevludin; Nyholm, Dag et al.

Ingår i ARTIFICIAL INTELLIGENCE IN MEDICINE, AIME 2019, s. 420-424, 2019

• DOI för Unsupervised Learning from Motion Sensor Data to Assess the Condition of Patients with Parkinson's Disease

Using measurements from wearable sensors for automatic scoring of Parkinson's disease motor states: results from 7 patients

Ilias, Thomas; Filip, Bergquist; Radu, Constantinescu; Nyholm, Dag et al.

Ingår i 2017 39th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), s. 131-134, 2017

• DOI för Using measurements from wearable sensors for automatic scoring of Parkinson's disease motor states: results from 7 patients

Feasibility of Spirography Features for Objective Assessment of Motor Symptoms in Parkinson's Disease

Sadikov, Aleksander; Zabkar, Jure; Mozina, Martin; Groznik, Vida et al.

Ingår i Artificial Intelligence In Medicine, s. 267-276, 2015

• DOI för Feasibility of Spirography Features for Objective Assessment of Motor Symptoms in Parkinson's Disease

Visualization of spiral drawing data of patients with Parkinson's disease

Jusufi, Ilir; Nyholm, Dag; Memedi, Mevludin

Ingår i 2014 18Th International Conference On Information Visualisation (IV), s. 346-350, 2014

• DOI för Visualization of spiral drawing data of patients with Parkinson's disease

Stochastic anomaly detection in eye-tracking data for quantification of motor symptoms in Parkinson's disease

Jansson, Daniel; Medvedev, Alexander; Axelson, Hans; Nyholm, Dag

Ingår i International Symposium on Computational Models for Life Sciences, s. 98-107, 2013

• DOI för Stochastic anomaly detection in eye-tracking data for quantification of motor symptoms in Parkinson's disease

Composite ⁶⁸Ge attenuation correction for quantitative brain PET/MR

Sousa, Joao M.; Appel, Lieuwe; Engström, Mathias; Papadimitrio, Stergios et al.

Comparison of quantitative [¹¹C]PE2I PET scans acquired on PET/MR and stand-alone PET

Sousa, Joao M.; Appel, Lieuwe; Engström, Mathias; Papadimitriou, Stergios et al.

CSF Proenkephalin decreases with the progression of Huntington's disease

Niemelä, Valter; Landtblom, Anne-Marie; Nyholm, Dag; Kneider, Maria et al.

Neural Fiber Activation in Unipolar vs Bipolar Deep Brain Stimulation

Frigge, Anna Franziska; Medvedev, Alexander; Jiltsova, Elena; Nyholm, Dag

TuneS: Patient-specific model-based  optimization of contact configuration in deep brain stimulation

Frigge, Anna Franziska; Uggla, Lina; Jiltsova, Elena; Fahlström, Markus et al.